IN-VITRO MODIFICATION OF DONOR BONE-MARROW USED TO PRODUCE ENHANCED GRAFT SURVIVAL IN ANTILYMPHOCYTE SERUM (ALS)-TREATED MICE

被引：0

作者：

GOZZO, JJ

WOOD, ML

POMPEI, R

MONACO, AP

机构：

[1] BOSTON CITY HOSP,TRANSPLANTATION DIV,SEARS SURG LAB,BOSTON,MA 02118

[2] HARVARD UNIV,MED SCH,DEPT SURG,BOSTON,MA 02115

来源：

TRANSPLANTATION PROCEEDINGS | 1973年 / 5卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：853 / 856

页数：4

共 50 条

[31] INFLUENCE OF SERUM INHIBITORS ON COLONY DEVELOPMENT IN-VITRO BY BONE-MARROW CELLS
CHAN, SH
AUSTRALIAN JOURNAL OF EXPERIMENTAL BIOLOGY AND MEDICAL SCIENCE, 1971, 49 (DEC): : 553 - &
[32] EFFECT OF CYCLOPHOSPHAMIDE ON SPECIFIC UNRESPONSIVENESS TO SKIN ALLOGRAFTS INDUCED IN ALS-TREATED MICE INFUSED WITH DONOR BONE-MARROW
WOOD, ML
MONACO, AP
JOURNAL OF IMMUNOLOGY, 1977, 118 (04): : 1456 - 1459
[33] PREVENTION OF GRAFT VERSUS HOST REACTION BY MEANS OF ALLOGENEIC ANTILYMPHOCYTE SERUM IN RATS FOLLOWING BONE-MARROW TRANSPLANTATION
JEANNET, M
VAUCHER, A
GERVASONI, C
SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1972, 102 (44) : 1598 - +
[34] INVITRO ANALYSIS OF IMMUNE REACTIVITY IN ALS-TREATED, BONE-MARROW INJECTED MICE BEARING ENHANCED SKIN ALLOGRAFTS
MAKI, T
GOTTSCHALK, R
HOMSY, FN
OKAZAKI, H
WOOD, ML
MONACO, AP
TRANSPLANTATION PROCEEDINGS, 1981, 13 (01) : 596 - 598
[35] POSSIBLE ACTIVE ENHANCEMENT OF A HUMAN CADAVER RENAL-ALLOGRAFT WITH ANTILYMPHOCYTE-SERUM (ALS) AND DONOR BONE-MARROW - CASE-REPORT OF AN INITIAL ATTEMPT
MONACO, AP
CLARK, AW
WOOD, ML
SAHYOUN, AI
CODISH, SD
BROWN, RW
SURGERY, 1976, 79 (04) : 384 - 392
[36] EFFECT OF CYTOXAN ON SKIN-GRAFT SURVIVAL IN ALS-TREATED, MARROW INFUSED MICE
WOOD, ML
MONACO, AP
FEDERATION PROCEEDINGS, 1977, 36 (03) : 1230 - 1230
[37] Expression of MHC class II antigen is essential in tolerance induction by donor bone marrow cell in antilymphocyte serum-treated and rapamycin-treated mice
Umemura, A
Monaco, AP
Maki, T
TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 148 - 148
[38] C-kit plus lin plus fraction of donor bone marrow (BM) possesses superior potency compared to whole BM in prolonging skin allograft survival in mice treated with antilymphocyte serum (ALS) and sirolimus.
Akpinar, E
Craighead, N
Anam, K
Smoot, D
Hale, D
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 189 - 189
[39] Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow
Hale, DA
Gottschalk, R
Maki, T
Monaco, AP
TRANSPLANTATION, 1998, 65 (04) : 473 - 479
[40] CELL-MEDIATED IMMUNITY AND SERUM BLOCKING FACTOR IN TOLERANCE PRODUCED IN MICE WITH ANTILYMPHOCYTE SERUM AND BONE-MARROW CELL INFUSION
WOOD, ML
HEPPNER, G
MONACO, AP
GOZZO, JJ
TRANSPLANTATION PROCEEDINGS, 1972, 4 (03) : 383 - &

← 1 2 3 4 5 →